Chiara Giannitti

ORCID: 0000-0002-8858-6362
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Therapeutic Uses of Natural Elements
  • Rheumatoid Arthritis Research and Therapies
  • Hepatitis C virus research
  • Myofascial pain diagnosis and treatment
  • Systemic Lupus Erythematosus Research
  • Cancer Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Osteoarthritis Treatment and Mechanisms
  • Medical Imaging and Pathology Studies
  • Lung Cancer Diagnosis and Treatment
  • Liver Disease Diagnosis and Treatment
  • MicroRNA in disease regulation
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Bone health and treatments
  • Spondyloarthritis Studies and Treatments
  • Musculoskeletal pain and rehabilitation
  • Cancer-related molecular mechanisms research
  • Complementary and Alternative Medicine Studies
  • Metastasis and carcinoma case studies
  • Cancer Genomics and Diagnostics
  • Breast Cancer Treatment Studies
  • Autoimmune and Inflammatory Disorders
  • Breast Implant and Reconstruction
  • IgG4-Related and Inflammatory Diseases
  • Cytokine Signaling Pathways and Interactions

University of Siena
2008-2020

Ospedale Santa Maria alle Scotte
2007-2017

Azienda Ospedaliera Universitaria Senese
2016-2017

Azienda Ospedaliera Santa Maria Degli Angeli
2012-2015

Indian Immunologicals (India)
2013

Weatherford College
2009

Sociedad Española de Reumatología
2006

Treatment of rheumatoid arthritis (RA)-related interstitial lung disease (ILD) is challenging, and many conventional biologic disease-modifying anti-rheumatic drugs (DMARDs) have been associated with ILD development or progression. The aim this multicentric retrospective study was to analyze the evolution in Italian RA-ILD patients treated abatacept (ABA).All ABA for at least six months were retrospectively evaluated. Serology, previous concurrent therapies, chest high-resolution computer...

10.3390/jcm9010277 article EN Journal of Clinical Medicine 2020-01-19

Objective To perform a cost‐effectiveness analysis of mud‐bath therapy (MBT) in addition to usual treatment compared alone patients with bilateral knee osteoarthritis (OA). Methods An economic evaluation alongside randomized controlled trial was conducted. Patients were randomly assigned receive either 2‐week cycle MBT their or continue routine care alone. The EuroQol 5‐domain questionnaire administered at baseline, 2 weeks, and 3, 6, 9, 12 months. Direct health resource consumption data up...

10.1002/acr.23116 article EN Arthritis Care & Research 2016-10-13

Objectives To translate the functional index for hand osteoarthritis (FIHOA) into Italian and to evaluate its reliability validity in patients with (HOA). Methods The original French FIHOA was translated according guidelines cross-cultural adaptation then administered 72 outpatients HOA, together visual analogue scale of pain (VAS), Health Assessment Questionnaire (HAQ) Short Form Survey (SF-36). Test–retest verified by having all fill out version again 1 week later. Item–item analysis...

10.1007/s10165-011-0579-4 article EN Modern Rheumatology 2012-01-15

Objectives To translate the functional index for hand osteoarthritis (FIHOA) into Italian and to evaluate its reliability validity in patients with (HOA). Methods The original French FIHOA was translated according guidelines cross-cultural adaptation then administered 72 outpatients HOA, together visual analogue scale of pain (VAS), Health Assessment Questionnaire (HAQ) Short Form Survey (SF-36). Test–retest verified by having all fill out version again 1 week later. Item–item analysis...

10.3109/s10165-011-0579-4 article EN Modern Rheumatology 2012-09-01

<h3>Background</h3> We have recently demonstrated that miR-223 is up-regulated in peripheral blood and synovial CD3+T lymphocytes (TL) from Rheumatoid Arthritis (RA) patients compared to healthy controls (1,2) suggesting could contribute the pathogenesis. Evidence exists miRNAs may circulate a highly stable form plasma serum (3). <h3>Objectives</h3> To evaluate levels CD3+TL of RA patients, at baseline (BL) after 6 months biological therapies; sera comparison donors. <h3>Methods</h3>...

10.1136/annrheumdis-2012-eular.1976 article EN Annals of the Rheumatic Diseases 2013-06-01

Objective: To test whether an association between HCV genotype, HLA class II alleles distribution and extra-hepatic manifestations (EHM ) can be demonstrated in a group of Italian patients with chronic infection . Methods: Sixty affected by EHM were consecutively enrolled. 163 without tested as controls for the prevalence genotypes, while we referred to literature distribution. HCV-RNA was quantified RT-PCR. typing performed using standard microlymphocytotoxicity assay. We used chi-square or...

10.4081/reumatismo.2008.192 article EN cc-by-nc Reumatismo 2011-09-12
Coming Soon ...